UK Statutory Scheme Rebate Rise Could Cause Product Shortages & Launch Delays

The pharmaceutical industry is calling on the government to take steps to restore the UK as a location for life sciences investment and recognize the role of competition in the branded generics market, but it will need strong evidence to make the most convincing case.